2021 Final Agenda

Tuesday, September 28

8:00 am Registration & Networking Breakfast
9:00 am

Welcome Remarks

Kirk Nielsen, Managing Partner, Vensana Capital
9:10 am

Medtech by the Numbers

Jonathan Norris, Managing Director, Venture Capital Relationships, Silicon Valley Bank

Venture capital fundraising boomed in 1H 2021. Investment into companies spiked to new records as well. This overview will review activity in venture healthcare in the first half of 2021, focusing on medical device investment and exit activity. This overview will review the top device indications by deals and dollars, the most active investors, and explore M&A and IPO activity, highlighting key trends in the sector.


Unicorns, IPOs, and SPACs – Perspectives on the Recent Historic Run of Mega-Deals

Panel Moderator:
Leslie Trigg, CEO, Outset Medical Inc
Jim Hinrichs, Board Member and Corporate Finance Professional, Outset Medical, Acutus Medical, Integer Holdings, Orthofix, Signifier Medical Technologies
James Rogers, Analyst, D1 Capital Partners

Company Building at a Time of Unprecedented Change and Uncertainty

Panel Moderator:
Stacy Enxing Seng, Venture Partner, Lightstone Ventures
Kevin Ballinger, CEO, Aldevron
Andrew Cleeland, CEO, Fogarty Innovation
Stacey Pugh, Chief Commercial Officer, Butterfly Network, Inc.
Sponsored by RSM
11:00 am Breakout Presentations and Discussions
David Gregory, MPA, FACHE, Principal, Healthcare Industry Leader, Baker Tilly
Barb Peterson, President & CEO, Emerson Consultants, Inc.
Lisa Wipperman-Heine, President & CEO, Precardia, Inc.
Patrice Kloss, Partner, Fox Rothschild
Steve Goedeke, President/CEO, Cardionomic, Inc.

Learn the pros and cons of structuring a strategic investment from experienced Medtech CEOs, along with guidance regarding governance, control, protection of intellectual property and additional rights often associated with strategic investments and acquisitions.

Bob Yedid, Managing Director, Investor Relations, LifeSci Partners
Rick Buchholz, Chief Financial Officer, Inspire Medical Systems, Inc.
Scott Janssen, Managing Director, LS Associates
Patrice Kloss, Partner, Fox Rothschild
11:50 am

Keynote 1:1 Interview: Medtech MVP 2021 Award Recipient

Tim Herbert, President & CEO, Inspire Medical Systems, Inc.
Interviewed By:
Marilyn Carlson Nelson, Former Chair & CEO, Carlson
Sponsored by Fox Rothschild

Venture Investing in a Post-COVID World

Panel Moderator:
Geoffrey Pardo, General Partner, Gilde Healthcare
Carter McNabb, Managing Director, River Cities Capital Funds
Darshana Zaveri, Managing Partner, Catalyst Health Ventures
Justin Klein, MD, JD, Co-Founder & Managing Partner, Vensana Capital
Tara Butler, MD, Managing Director, Ascension Ventures

The Emergence of Data Science as a Core Medtech Pillar

Panel Moderator:
Jan Garfinkle, Managing Partner, Arboretum Ventures
Mick Farrell, CEO, ResMed Corp
E. Selemon Asfaw, Chief Financial Officer, OptumCare
Brian Miller, Ph.D., Chief Digital Officer, Intuitive
Renee C Ryan, CEO, Cala Health Inc
2:05 pm Networking Refreshment Break
2:20 pm Breakout Presentations and Discussions
Goktug Aksan, Director, Technology Risk Consulting, Consulting, RSM US LLP

Keeping abreast of cyberthreats is challenging; however, an understanding of the most common cyber risks,  and an awareness of current cyberthreat landscape by business leaders, alongside with use of tools and technologies designed for strengthening the security posture of their organizations, could help to avoid and mitigate against cyber risks

Mark DuVal, President and CEO, DuVal & Associates
Bryan Feldhaus, Vice President of Legal-Regulatory and Compliance, DuVal & Associates

Provide an update on what is happening at FDA

Discuss the Pre-Submission program, the Breakthrough Device program, and the 510(k) program including FDA’s reshaping of it


Mike Fix, Director, Life Sciences, Guidehouse
Chris Condes, Managing Consultant, Life Sciences, Guidehouse

Consumer receptivity to telemedicine and digital therapeutics has increased dramatically during the global COVID-19 pandemic, but significant barriers remain for patients, providers, and payers. Come discuss area where Digital MedTech is gaining traction, and keys to its persistence in a post-pandemic world.


View from the Beltway: What Should We Expect from the New Administration, FDA, and CMS?

Panel Moderator:
Scott Whitaker, President & CEO, AdvaMed
Anand Shah, MD, Former Deputy Commissioner for Medical and Scientific Affairs, FDA
Nadim Yared, President & CEO, CVRx

Corporate Development Roundtable: What are Strategics Prioritizing in the New Normal?

Panel Moderator:
J.P. Peltier, Managing Director, Global Head, Healthcare Investment Banking, Piper Sandler
Charlie Attlan, Senior Vice President, Corporate Strategy and Business Development, Boston Scientific Corp
Eric Schantz, Vice President, Corporate Development, Medtronic Inc
Rachel Ellingson, SVP, Chief Strategy Officer, Zimmer Biomet
Christos Monovoukas, Vice President, Global M&A & Bus Dev, Olympus Corporation of the Americas
Jennifer Mischke, Senior Vice President of Global Clinical, Consulting & IVD Services, Operations, NAMSA
4:25 pm

Keynote 1:1 Executive Interview

Lisa Earnhardt, Executive Vice President, Medical Devices, Abbott
Interviewed By:
Nicole J Walker, Managing Partner, Arboretum Ventures
4:50 pm

Closing Remarks

Kirk Nielsen, Managing Partner, Vensana Capital
Sponsored by Intuitive
6:00 pm Close of Conference